- Citations, last 5 years
- 680
- Works, last 5 years
- 184
- h-index
- 83
- Scientists listed
- 13
- Grants since 2016
- 1 402
Grants received
2018–2020 · research · R21
Efflux pumps and the emergence of antibiotic resistance in single cells
Mary Dunlop · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
Cortical Interactions Underlying Sensory Representations
Jerry L Chen · Charles River Associates · funded by National Institutes of Health
2018–2024 · research · R25
Flipped Biomedical Grand Rounds: Creating a Clinical Immersion Classroom
Catherine M. Klapperich · Charles River Associates · funded by National Institutes of Health
2018–2021 · fellowship · F32
Development of Episodic Future Thinking: Limits, Flexibility, and Neural Correlates
Tashauna Blankenship · Charles River Associates · funded by National Institutes of Health
2018–2021 · fellowship · F31
Clinical Feasibility of Chemotherapy Monitoring for Sarcoma with Diffuse Optical Spectroscopic Imaging
Hannah Marie Peterson · Charles River Associates · funded by National Institutes of Health
2018–2022 · research · R24
Establishing an fNIRS Ecosystem for Open Software-Hardware Dissemination
David A Boas · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R01
Highly Sensitive Chemical Microscopy by Probing the Thermal Effect of Infrared Light
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R01
Advanced Risk Adjusters and Predictive Formulas for ICD-10 Based Risk Adjustment
Randall P. Ellis · Charles River Associates · funded by Agency for Healthcare Research and Quality
2018–2022 · research · R01
Highly Sensitive Chemical Microscopy by Probing the Thermal Effect of Infrared Light
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
Voice and Speech Sensorimotor Control in Parkinsons Disease
Frank H Guenther · Charles River Associates · funded by National Institutes of Health
2018–2023 · career development · K01
Preventing Alcohol and Other Drug Use and Violence among Latino Youth
Christopher Patrick Salas-Wright · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R21
Development of label-free computational flow cytometry for high-throughput micro-organism classification
Jerome Mertz · Charles River Associates · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
A multi-scale computational model of the extracellular matrix of the lung
Bela Suki · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R35
Integrative Approaches for Probing Cell Mechanotransduction in Health and Disease
John Tuan Ngo · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R03
Cortical development and neuroanatomical anomalies in developmental dyslexia
Tyler Perrachione · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R13
Academy of Aphasia Research and Training Symposium
Swathi Kiran · Charles River Associates · funded by National Institutes of Health
2018–2022 · research · R01
Advanced Risk Adjusters and Predictive Formulas for ICD-10 Based Risk Adjustment
Randall P. Ellis · Charles River Associates · funded by Agency for Healthcare Research and Quality
2018–2023 · research · R01
Unveiling the mechanisms of ultrasound neuromodulation via spatially confined stimulation and temporally resolved recording
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE
Yolonda L Colson · Charles River Associates · funded by National Institutes of Health
2018–2024 · research · R25
Supporting postdoctoral mentoring relationships through expanding the Postdoc Academy program
Bennett B Goldberg · Charles River Associates · funded by National Institutes of Health
2018–2024 · research · R33
Nature and Predictors of Impaired Harm Avoidance in Polysubstance Abuse
Kathleen M. Kantak · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R33
Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R13
Academy of Aphasia Research and Training Symposium
Swathi Kiran · Charles River Associates · funded by National Institutes of Health
2018–2021 · fellowship · F32
Development of Episodic Future Thinking: Limits, Flexibility, and Neural Correlates
Tashauna Blankenship · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R35
The coordination of cell death and corpse clearance
Kimberly A Mccall · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R25
Flipped Biomedical Grand Rounds: Creating a Clinical Immersion Classroom
Catherine M. Klapperich · Charles River Associates · funded by National Institutes of Health
2018–2022 · research · R21
A Rapid and Sensitive Antibiotic Susceptibility Test for Urinary Tract Infections
Kamil Ekinci · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
Voice and Speech Sensorimotor Control in Parkinsons Disease
Frank H Guenther · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R24
Establishing an fNIRS Ecosystem for Open Software-Hardware Dissemination
David A Boas · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R01
Measuring, Modeling, and Modulating Cross-Frequency Coupling
Uri Tzvi Eden · Charles River Associates · funded by National Institutes of Health
2018–2022 · research · R01
Cortical Interactions Underlying Sensory Representations
Jerry L Chen · Charles River Associates · funded by National Institutes of Health
2018–2022 · research · R61
Effect of opioid use disorder on HIV latent reservoirs and immune dysfunction assessed by single-cell transcriptomics
Christine Cheng · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R35
Structure and Function of Immune Gene Regulatory Networks
Juan Ignacio Fuxman Bass · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R35
Integrative Approaches for Probing Cell Mechanotransduction in Health and Disease
John Tuan Ngo · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
The impact of microvascular (dys)regulation on cerebral flow and oxygen heterogeneity
David A Boas · Charles River Associates · funded by National Institutes of Health
2018–2021 · career development · K01
Weighting of auditory information
Elin Roverud · Charles River Associates · funded by National Institutes of Health
2018–2027 · research · R01
Rapid AST through Metabolic Imaging at Single Cell Level
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2018–2023 · research · R01
Walking and mHealth to Increase Participation in Parkinson Disease (WHIP-PD)
Gammon M. Earhart · Charles River Associates · funded by National Institutes of Health
2018–2021 · research · R21
Nature and Predictors of Impaired Harm Avoidance in Polysubstance Abuse
Kathleen M. Kantak · Charles River Associates · funded by National Institutes of Health
2018–2022 · career development · K01
Weighting of auditory information
Elin Roverud · Charles River Associates · funded by National Institutes of Health